NiKang Therapeutics, Inc. of Wilmington, DE, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-07. The offering totals $200.0M, of which $200.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Sean Cao | Director | Wilmington, DE |
| Wei Fu | Director | Grand Cayman, E9 |
| Zhenhai Gao | Director | Wilmington, DE |
| Ting Jia | Director | New York, NY |
| Roderick Wong | Director | New York, NY |
| Zhengbin Yao | Director | South San Francisco, CA |
| Gary Yeung | Director | Burlingame, CA |
| Hong (Kelsey) Chen | Executive Officer | Wilmington, DE |
| Zhenhai Gao | Executive Officer | Wilmington, DE |